Predictions
Formycon AG
Start price
Target price
Perf. (%)
€60.40
18.01.21
18.01.21
€80.00
18.01.22
18.01.22
-9.93%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€4.40
26.09.21
26.09.21
-
26.09.22
26.09.22
-6.82%
03.10.21
03.10.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Heidelberg Pharma AG
Start price
Target price
Perf. (%)
€5.64
27.01.21
27.01.21
€8.00
27.01.22
27.01.22
9.75%
28.09.21
28.09.21
Could be worthwhile Investment >10% per year
Sartorius AG VZO
Start price
Target price
Perf. (%)
€413.70
18.06.21
18.06.21
€600.00
18.06.22
18.06.22
35.75%
27.09.21
27.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
High valuation
Nanorepro AG
Start price
Target price
Perf. (%)
€8.60
15.02.21
15.02.21
€20.00
15.02.22
15.02.22
5.47%
23.09.21
23.09.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Merck KGaA
Start price
Target price
Perf. (%)
€144.55
11.01.21
11.01.21
€145.00
11.01.22
11.01.22
42.10%
12.09.21
12.09.21
Could be very worthwhile Investment >20% year
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€39.22
04.01.21
04.01.21
€75.00
04.01.22
04.01.22
11.33%
05.09.21
05.09.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
MorphoSys AG
Start price
Target price
Perf. (%)
€47.81
30.08.21
30.08.21
€53.00
30.08.22
30.08.22
5.67%
04.09.21
04.09.21
Could be worthwhile Investment >10% per year
Innovative
Top 10 in its market
Higher risks for its business
Nanorepro AG
Start price
Target price
Perf. (%)
€16.00
12.03.21
12.03.21
€22.00
12.03.22
12.03.22
-62.19%
12.08.21
12.08.21
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Higher risks for its business
Bio-Gate AG
Start price
Target price
Perf. (%)
€2.30
17.06.20
17.06.20
€5.00
04.11.21
04.11.21
73.91%
12.08.21
12.08.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Higher risks for its business
High valuation
Stratec SE
Start price
Target price
Perf. (%)
€121.80
20.07.21
20.07.21
€135.00
20.07.22
20.07.22
4.76%
30.07.21
30.07.21
Risky Investment
Paul Hartmann AG
Start price
Target price
Perf. (%)
€360.00
14.07.21
14.07.21
€450.00
14.07.22
14.07.22
0.28%
24.07.21
24.07.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.83
08.02.21
08.02.21
€41.00
16.07.21
16.07.21
27.92%
16.07.21
16.07.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€36.97
12.11.20
12.11.20
€50.00
12.11.21
12.11.21
21.49%
13.07.21
13.07.21
Top 10 in its market
Small cyclical dependencies
Below average Management
Paul Hartmann AG
Start price
Target price
Perf. (%)
€353.00
30.06.21
30.06.21
€400.00
30.06.22
30.06.22
3.40%
10.07.21
10.07.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Drägerwerk AG & Co. KGaA VZO
Start price
Target price
Perf. (%)
€69.30
21.01.21
21.01.21
-
21.01.22
21.01.22
17.39%
29.06.21
29.06.21
Bio-Gate AG
Start price
Target price
Perf. (%)
€3.30
02.06.21
02.06.21
-
02.06.22
02.06.22
9.09%
20.06.21
20.06.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Stratec SE
Start price
Target price
Perf. (%)
€105.60
28.08.20
28.08.20
€95.00
04.11.21
04.11.21
5.30%
17.06.21
17.06.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
Very low/no dividend yield expected